Description
Tagrisso 80 mg (Osimertinib) Film coated tablets — Advanced Targeted Therapy for EGFR-Mutated Lung Cancer
Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor. Osimertinib was approved for medical use in the United States in November 2015, and in the European Union in February 2016.
- Common side effects include diarrhoea, rash, dry skin, nail toxicity (paronychia), stomatitis, and fatigue.
Osimertinib is available in India on request-
Lucknow Speciality Pharma is the leading Pharma brand and one of the most leading Pharma Wholesalers in Lucknow. We are expanding our reach across India. To get “Tagrisso (Osimertinib)“, patients can simply fill the order form or can send mail at info@lucknowpharma.com. Patients can also send WhatsApp messages to +91-9555306364, The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.





